Close Menu

NEW YORK (GenomeWeb) – Luminex today announced that it has received 510(k) clearance from the US Food and Drug Administration for its Aries System and Aries Herpes Simplex Virus (HSV) 1&2 Assay.

The real-time PCR-based sample-to-answer Aries system detects and amplifies nucleic acids. It uses cartridges, internal barcode scanning, and other features to minimize operator errors and has a built-in touchscreen computer to save benchtop space.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US National Institutes of Health's All of Us project awarded $4.6 million to the company Color to develop a genetic counseling resource for the program.

The Times of India reports on a pilot study that used genomic testing to determine whether patients had drug-resistant tuberculosis.

New guidelines say that more women may benefit from genetic testing for hereditary breast or ovarian cancer, according to the Los Angeles Times.

In Cell this week: small proteins identified among human microbiome, role for tumor microbes in pancreatic cancer survival, and more.